Related Experiment Video
Updated: Apr 6, 2026

11:42
Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration
Published on: September 12, 2014
12.8K
Next-generation smart ophthalmic biomaterials: From passive response to active interaction and closed-loop control
Pengbo Zhang1,2, Yan Nie1,2, Xiaofang Wang3
1Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Bioactive Materials
|November 14, 2025
Summary
Ophthalmic biomaterials are evolving from passive implants to intelligent, adaptive systems. Future closed-loop ocular therapies will integrate sensing, decision-making, and actuation for autonomous disease management.
Area of Science:
- Biomaterials Science
- Ophthalmology
- Regenerative Medicine
Background:
- Conventional ophthalmic biomaterials are largely inert, lacking the ability to adapt to the dynamic ocular microenvironment.
- Current stimuli-responsive materials are often reactive or preprogrammed, failing to provide autonomous control.
- The ocular microenvironment presents complex biochemical and biomechanical challenges for material performance.
Purpose of the Study:
- To present an evolutionary framework for ophthalmic biomaterials, from passive to closed-loop systems.
- To synthesize advances in stimuli-responsive and intelligent biomaterial platforms for ocular applications.
- To identify design principles and challenges for next-generation, self-adaptive ocular therapies.
Main Methods:
- Literature synthesis and conceptual framework development.
- Analysis of biomaterial generations based on responsiveness and control.
- Identification of key design principles for intelligent ophthalmic systems.
Main Results:
- Ophthalmic biomaterials are transitioning through three generations: passive, interactive, and closed-loop.
- Closed-loop systems integrate sensing, on-board decision-making, and actuation for autonomous function.
- Key challenges include systems-level integration and achieving true self-adaptation.
Conclusions:
- Intelligent, self-adaptive ophthalmic biomaterials offer a conceptual basis for next-generation ocular therapies.
- Future research should focus on rational design principles for closed-loop systems.
- Autonomous control represents a critical frontier in ophthalmic biomaterial development.
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
124
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
124
Ophthalmic Drug Delivery Systems
224
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
224

